Alzheimer’s Biomarkers From Multiple Modalities Selectively Discriminate Clinical Status: Relative Importance of Salivary Metabolomics Panels, Genetic, Lifestyle, Cognitive, Functional Health and Demographic Risk Markers October 2, 2018 Article 2 of 20899
Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies October 2, 2018 Article 3 of 20899
Application of Bézier Curves for Calculating Likelihood Ratios for Plasma Amyloid-β Biomarkers for Alzheimer’s Disease October 2, 2018 Article 4 of 20899
Virtual reality can reduce pain and increase performance during exercise October 1, 2018 Article 10 of 20899
Judges In California Losing Sway Over Court-Ordered Drug Treatment October 1, 2018 Article 11 of 20899
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ1–42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment October 1, 2018 Article 12 of 20899